Skip to main content

Sexual forms obtained in a continuous in vitro cultured Colombian strain of Plasmodium falciparum (FCB2)



The epidemiological control of malaria has been hampered by the appearance of parasite resistance to anti-malarial drugs and by the resistance of mosquito vectors to control measures. This has also been associated with weak transmission control, mostly due to poor control of asymptomatic patients associated with host-vector transmission. This highlights the importance of studying the parasite’s sexual forms (gametocytes) which are involved in this phase of the parasite’s life-cycle. Some African and Asian strains of Plasmodium falciparum have been fully characterized regarding sexual forms’ production; however, few Latin-American strains have been so characterized. This study was aimed at characterizing the Colombian FCB2 strain as a gametocyte producer able to infect mosquitoes.


Gametocyte production was induced in in vitro cultured P. falciparum FCB2 and 3D7 strains. Pfap2g and Pfs25 gene expression was detected in FCB2 strain gametocyte culture by RT-PCR. Comparative analysis of gametocytes obtained from both strains was made (counts and morphological changes). In vitro zygote formation from FCB2 gametocytes was induced by incubating a gametocyte culture sample at 27 °C for 20 min. A controlled Anopheles albimanus infection was made using an artificial feed system with cultured FCB2 gametocytes (14–15 days old). Mosquito midgut dissection was then carried out for analyzing oocysts.


The FCB2 strain expressed Pfap2g, Pfs16, Pfg27/25 and Pfs25 sexual differentiation-related genes after in vitro sexual differentiation induction, producing gametocytes that conserved the expected morphological features. The amount of FCB2 gametocytes produced was similar to that from the 3D7 strain. FCB2 gametocytes were differentiated into zygotes and ookinetes after an in vitro low-temperature stimulus and infected An. albimanus mosquitoes, developing to oocyst stage.


Even with the history of long-term FCB2 strain in vitro culture maintenance, it has retained its sexual differentiation ability. The gametocytes produced here preserved these parasite forms’ usual characteristics and An. albimanus infection capability, thus enabling its use as a tool for studying sexual form biology, An. albimanus infection comparative analysis and anti-malarial drug and vaccine development.


Almost half of the world’s population is at risk of malaria infection caused by the intracellular parasite Plasmodium. The World Health Organization (WHO) estimated 219 million cases for 2017, representing a 2 million case increase compared to 2016 [1]. Two hosts are involved in the parasite’s biological cycle: the mosquito vector (where parasite sexual differentiation occurs) and the human host (where asexual replication prevails) [2]. The parasite’s sexual phase (related to human-vector transmission) starts just after the female Anopheles mosquito’s uptake of infected erythrocytes having parasite sexual forms (gametocytes) after biting an infected human. Sexual form fusion (macrogamete and microgamete) occurs inside the mosquito midgut; gametes then mate to form zygotes, which transform into ookinetes and embed themselves within insect midgut epithelial cells [3, 4]. Physiological conditions occur simultaneously during the ookinete stage thereby facilitating parasite mobility and oocyst formation and maturation; ookinetes differentiate into oocysts and release large amounts of sporozoites into the haemocoel upon maturation which are responsible for mosquito vector-human transmission [3, 5].

Gametocyte blockade is thus considered a good target for vaccine development because it is intended to stall the disease at human-vector transmission level [6, 7]. Small quantities of gametocytes circulate in infected humans’ bloodstreams, being exposed to the host immune system; ookinetes could come into contact with the mosquito’s immune system that includes a complement-like immune response [8,9,10]. The host’s immune response gradually controls Plasmodium dispersal by reducing the amount of circulating gametocytes and limiting parasite development inside the mosquito vector, making this Plasmodium sexual stage an important biological bottleneck [11, 12]. However, even with such biological control, natural response against the parasite leaves asymptomatic human parasite carriers (i.e. an important cause of transmission) [7, 8]. Parasite culture and the biological study of sexual-stage parasite antigens are important for identifying and selecting effective vaccine candidates to stop this never-ending infection cycle [13].

It is known that infection susceptibility and disease transmission through Anopheles is determined by the genetic characteristics of the mosquito and the parasite [4]. Mosquito immune pressure generates genetic changes in P. falciparum, thereby enabling its gradual adaptation to mosquitoes from different geographical regions [11]. Parasite-vector interaction has been extensively followed up in African mosquitoes because of the ease of parasite isolate availability and the ease of establishing mosquito colonies to facilitate studying the mosquito’s immune response [14,15,16,17]. Comparative analysis of parasite compatibility with mosquitoes from Africa and Southeast Asia has found parasite adaptive mechanisms regarding each Anopheles species; a similar approach has been followed with the Latin-American P. falciparum strain 7G8 and Anopheles albimanus [15]. Even so, knowledge is still lacking about the interaction of other Latin-American parasite strains with New World mosquitoes [18]. This has mostly been due to difficulties in establishing Anopheles colonies (from the New World, especially regarding epidemiologically important mosquito strains) and also the lack of parasite strains from this geographical area having characterized sexual differentiation capability [18,19,20,21].

Plasmodium falciparum strains can be stimulated in vitro for gametocyte production; these sexual forms could be used in antibody invasion inhibition studies and testing candidate antigens for vaccine development [22]. Some P. falciparum strains (such as NF54) continuously cultured in vitro keep their sexual differentiation capability; however, many lose it because of spontaneous genetic mutations of sexual differentiation-related transcription factors, like the apetala 2-gametes (ap2-g) transcription factor [23].

A group of Colombian P. falciparum isolates were adapted to continuous in vitro culture more than 30 years ago; the falciparum Colombia Bogotá 2 (FCB2) strain (an in vitro culture-adapted isolate from Colombia’s Eastern Plains) from that group was described as having sexual differentiation capability [24]. This strain has been used for antigen analysis when developing an anti-malarial vaccine and in studies of the human immune response against the parasite [25,26,27]. This strain has been maintained in in vitro continuous culture since then but it was not known if it conserved its sexual differentiation ability or whether sexual forms could evolve to mature forms and infect local Anopheles species [24].

The purpose of this study was thus to induce Colombian FCB2 strain gametocyte production and prove its infective ability by controlled female Anopheles mosquito infection using an artificial feeding system involving parasitized erythrocytes. These FCB2 strain sexual forms (having mosquito infective capability) could thus be used in comparative studies with other P. falciparum strains for evaluating antibodies produced against antigens, representing promising candidates for blocking malarial transmission [28, 29]. This information increases knowledge about this specific Colombian parasite strain and provides another tool for developing anti-malarial drugs and vaccine candidates tackling parasite transmission.


Plasmodium falciparum in vitro culture

3D7 (BEI Resources Repository, NIAID, NIH: Plasmodium falciparum, Strain 3D7, MRA-102, contributed by Daniel J. Carucci) and FCB2 parasite strains were cultured with O+ human erythrocytes in RPMI 1640 culture media, supplemented with human inactivated serum, in a 90% N2, 5% O2, 5% CO2 atmosphere [30]. The maintenance protocol of asexual and sexual forms of Delves et al. was followed [22]. Briefly, asexual parasite form culture was checked every 48 h, maintaining 0.5% culture parasitaemia in 4% haematocrit until gametocytes became mature (gametocyte stage V) after 12 to 15 days culture involving daily medium replacement, without adding fresh erythrocytes. The gametocytes were then tested regarding their sexual differentiation capability in vitro, using 100 µL gametocyte culture (stage V) at 27 °C for 20 min [31]. Samples were then spun at 2500 rpm for 3 min, pellets were analysed by Giemsa staining and gametes were visualized at 40× using a Primo Star Carl Zeiss microscope [32].

An exflagellation test was made on gametocyte culture; 50 µL mature gametocyte culture mixed with human serum was kept at room temperature for 10 min. The cells were visualized in a Neubauer chamber at 40x using a Primo Star Carl Zeiss microscope. Exflagellation centres were counted and exflagellation percentage calculated using the following equations [22]:

$$Culture\;exflagellation\;per\;mL = mean\;of\;exflagellation\;on\;4\;grids \,\times\, 2 \left( {dilution\;factor} \right) \,\times\, 10^{4}$$
$$Erythrocytes\;per\;mL = mean\;erythrocytes\;in\;16\;small\;squares \,\times\, 100 \,\times\, 2 \left( {dilution\;factor} \right) \,\times\, 10^{4}$$
$$Percentage\;exflagellating\;cells = \frac{culture\;exflagellation\;per\;mL}{erythrocytes\;per\;mL} \times 100$$

PCR and DNA sequencing

Plasmodium falciparum FCB2 strain genomic DNA was extracted from parasite in vitro culture using an UltraClean BloodSpin DNA Isolation Kit (MO BIO) and stored at − 70 °C until use. The PfRh1 and Pfmsp2 genes were amplified using previously reported primers for PfRh1 [33] (Pfrh1F-AATACACATAATAAGAAGAACC, Pfrh1R-TAGTGAATGTTCGTTATCTTG) and the following primers for Pfmsp2 (Pfmsp2F-AAAACATTGTCTATTATAAATTTC, Pfmsp2R-TGCATCATTAGTAGTTGTGG). Phusion Hot Start II High-Fidelity PCR Master Mix (ThermoFisher) in a BioRad T100 thermal cycler was used for PCR amplification. A Wizard SV Gel and PCR Clean-Up System (Promega) was used for purifying PCR products which were then sequenced using the Sanger method (Macrogen).

SnapGene software (from GSL Biotech; available at was used for manually editing the DNA sequences and ClustalW for aligning them [34]. EMBL-EBI MUSCLE software was used for multiple sequence alignment against reported Pfrh1 and Pfmsp2 sequences from other P. falciparum strains (3D7, NF54, HB3, FVO, CAMP/Malaysia, Senegal, D10, IT and 7G8) and visualized using MView software.

RNA extraction and cDNA synthesis

In vitro gametocytes (from parasite culture) were used for RNA extraction; 0.2% saponin was used in gametocyte-parasitized erythrocyte soft lysis. TRIzol LS (Invitrogen)-chloroform treatment was then used for RNA extraction, following the manufacturer’s recommendations. A SuperScript III Reverse Transcriptase kit (Thermo Fischer Scientific) was used for cDNA synthesis, following the manufacturer’s recommendations. All samples’ concentrations were measured by spectrophotometry (at 260 nm) and stored at − 70 °C until use.


Primers were designed for analysing Pfs25 (PF3D7_1031000), Pfg27/25 (PF3D7_1302100), Pfs16 (PF3D7_0406200) and Pfap2g (PF3D7_1222600) gene transcription, using the 3D7 sequence as reference. BLAST was used for aligning these genome sequences with other P. falciparum strains; Primer3web software ( was used for designing the primers, using conserved regions. A pair of primers was designed from each gene (Pfs25F-CCATGTGGAGATTTTTCCAAATGTA, Pfs25R-CATTTACCGTTACCACAAGTTACATTC; Pfg27/25F-TGACAATGTTATCTTGGACACGT, Pfg27/25R-CCCCTCTCTCACCTCGTATT; Pfs16F-CCCCTCTCTCACCTCGTATT, Pfs16R-CCCCTCTCTCACCTCGTATT; Pfap2gF-CGAATGGGAAGAGAGCATGC, Pfap2gR-TCGCTTTCTTGTCCATGCAA). The NCBI Primer-BLAST tool ( was used for testing primer specificity. Go Taq DNA polymerase (Promega) was used for RT-PCR which was carried out on a Bio-Rad T100 thermal cycler. All PCR amplifications were resolved on 1.5% agarose gel stained with SYBR safe.

Anopheles albimanus and Anopheles stephensi infection and dissection

The An. albimanus Buenaventura strain (originated from Colombia, kindly provided by the Instituto Nacional de Salud de Colombia) and Anopheles stephensi STE2 strain (originated from India, kindly provided by Doctors Ana Catarina Alves, Henrique Silveira and João Pinto, from the Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Portugal) mosquitoes were bred at 26 ± 2 °C temperature, 60–80% relative humidity and 12 h light/dark cycles. Adults were fed with 10% sugar solution. Two to three days after eggs hatched, a maximum of 250 larvae were placed in plastic recipients and fed daily with powdered sterilized cat food [16]. Three- to six-day-old emerged female mosquitoes were used for infection assays; this involved collecting 100–150 individuals in plastic recipients covered with fine pore black netting [35]. Gametocyte culture (14–15 days old) for mosquito feeding was pelleted and diluted at 40% haematocrit with human O+ erythrocytes, supplemented with inactivated human plasma [36]. Females were then fed for 20 to 30 min on pig membranes, using an artificial feed system. After being fed with gametocytes, mosquitoes were kept for 12 to 15 days in the aforementioned conditions [35, 36].

Parasite forms in the mosquitoes’ midgut were followed-up by dissection during different parasite growth stages. A standard 0.5% mercurochrome midgut stain was used for parasite form count. Each individual’s infection rate (percentage of mosquitoes infected in the midgut) and infection intensity (the median of oocysts in mosquito midgut) was recorded and compared to experimental groups (FCB2) [5]. In vivo gametocyte infectivity was determined by analysing oocysts’ phenotypical characteristics in mosquito midgut [17].

Statistical analysis

STATA 14 software was used for all statistical analysis (0.05 significance level). Data was reported as percentages. A Chi2 test was used for establishing statistical differences between group percentages; the quantitative variables in this study were described with their respective medians and interquartile ranges (IQR). A Mann–Whitney U test was used for comparing median values.


Plasmodium falciparum FCB2 strain molecular characterization

The P. falciparum FCB2 strain has been maintained for a long time under in vitro culture. Pfrh1 [33], and Pfmsp2 were sequenced and aligned against 3D7, NF54, FVO, HB3, Camp/Malaysia, Senegal, D10, 7G8 and IT P. falciparum strains for determining that the FCB2 strain was not contaminated with other P. falciparum strains. Some nucleotide changes are seen for Pfrh1 (3086A>T SNP in FVO, Camp/Malaysia and Senegal strains sequences 3064T>C SNP in 3D7, NF54, HB3 and 3921A>G SNP in Camp/Malaysia and Senegal strains), as well as multiple changes in the Pfmsp2 sequence (Additional file 1).

Plasmodium falciparum FCB2 strain genetic gametocyte production capability

It is known that continuous in vitro Plasmodium strain culture tends to delete genes which are important for sexual differentiation, thereby decreasing or impairing parasite gametocyte production capability [23, 37, 38]. The most important genetic change associated with the loss of the parasite sexual differentiation capability is related to the deletion or absence of Pfap2g gene expression [37]. The P. falciparum FCB2 strain has been kept in continuous in vitro culture for nearly 30 years, probably losing sexual differentiation capability associated with a loss of Pfap2g expression. Pfap2g gene expression was verified by RT-PCR; Pfap2g gene expression was found in these parasites after having induced parasite differentiation to sexual forms in in vitro culture (Fig. 1); no Pfap2g expression was seen in non-induced culture (Fig. 1). RT-PCR was used to verify the FCB2 strain’s genetic sexual differentiation capability; it corroborated Pfs25, Pfs16 and Pfg27/25 gene transcription [39,40,41,42] by RT-PCR, amplifying the specific band (Fig. 1).

Fig. 1

Pfs25 and Pfap2g expression. RT-PCR was used for analysing Pfs25, Pfs16, Pfg27/25 and Pfap2g gene expression in the in vitro cultured P. falciparum FCB2 strain induced for sexual differentiation. a FCB2 Pfap2g and Pfs25 amplification; b FCB2 Pfg27/25 amplification. c FCB2 Pfs16 amplification. 1: Asexual parasite in vitro culture, 2: Gametocyte in vitro culture, M: molecular weight marker, NC: negative control

Plasmodium falciparum FCB2 strain gametocyte production

Pfap2g, Pfs16, Pfg27/25 and Pfs25 gene transcription suggested the FCB2 strain’s sexual differentiation capability but did not prove gametocyte development. Morphological analysis of the forms produced by this parasite followed gametocyte production induction; such changes were evaluated for 12 to 15 days until the gametocytes reached their full mature morphology [22]. The parasites started to have clear morphological differentiation by day 4, beginning with a larger round shape which started to differentiate from the trophozoite forms. They then progressed to a D form before progressing to full mature gametocyte morphology from day 13 onwards (Figs. 2 and 3), as expected for gametocytogenesis [43]. FCB2 strain gametocytes conserved most of the expected features, having smooth and normal-sized parasite forms during each stage [44, 45] (Fig. 2).

Fig. 2

Morphological characteristics of gametocytes produced by the Plasmodium falciparum FCB2 strain. FCB2 strain gametocytes obtained from parasite culture at 0.3% parasitaemia were analysed by Giemsa staining. Gametocytes were visualized at 100X on a Primo Star Carl Zeiss microscope and 3 biological replicates were performed, counting minimum 3 fields per replica. Black arrows indicate parasite forms. A FCB2 gametocyte stage I–II; B FCB2 gametocyte stage II–III; CE FCB2 gametocyte stage IV–V; F, G FCB2 form similar to zygote stage; H FCB2 form suggesting ookinete stage

Fig. 3

Plasmodium falciparum FCB2 and 3D7 gametocyte production. FCB2 and 3D7 strains’ gametocytes were obtained from parasite culture at 0.3% parasitaemia, analysed by Giemsa staining and parasitaemia and gametocyte stages were estimated by counting at 40X on a Primo Star Carl Zeiss microscope. 3 experimental replicates were made. a Relationship between FCB2 strain days’ culture and parasitaemia (Lines) and that for 3D7 strain (grey bars); b Number of FCB2 strain gametocytes at different stages according to the days in culture

FCB2 gametocyte production was analysed using the P. falciparum 3D7 strain as control. Sexual differentiation was induced in both in vitro cultured strains; the sexual forms obtained in each strain were counted, finding similar FCB2 strain gametocyte production (0.2% gametocytaemia) compared to that for the 3D7 strain (0.8% gametocytaemia) (Fig. 3a). A previous study reported maximum 0.8% 3D7 gametocytaemia, thereby supporting our findings [46].

An exflagellation test was made after inducing sexual differentiation, finding 0.45% exflagellated cells in in vitro gametocyte culture, compared to 1.08% in 3D7 gametocyte culture (Fig. 4).

Fig. 4

Plasmodium falciparum FCB2 exflagellation. FCB2 and 3D7 gametocyte culture exflagellation was induced by putting 50μl gametocyte culture sample at room temperature for 10 min. AC FCB2 exflagellated microgametes; D exflagellation percentages (EP) were calculated for each strain (3D7 and FCB2); 3 experimental replicates were made. Exflagellated forms, analysed by Giemsa staining, were visualized at 100X on a Primo Star Carl Zeiss microscope

Plasmodium falciparum FCB2 strain gametocyte infectivity

In vitro zygote formation was evaluated after placing FCB2 strain gametocyte culture samples in low temperature conditions (23 °C) to assess whether FCB2 strain gametocytes could infect mosquitoes. Round-shaped parasite forms (i.e. zygote forms) were observed, almost the same size as an erythrocyte (Fig. 2) [47]. Gametocyte infectivity was then analysed in vivo determining the amount of oocysts and their phenotypic characteristics in the mosquitoes’ midgut.

Female An. albimanus Buenaventura strain were fed with FCB2 gametocyte culture at 40% haematocrit, with human O+ erythrocytes. An initial FCB2 oocyst quantification in mosquito midgut until 10 to 12 days post-feeding show that the median value was higher on day 8 (median 64, interquartile range (IQR) 40) compared to day 12 (median 35, IQR 48); median distribution regarding the days evaluated here was statistically significant (p = 0.0147, U test) (Fig. 5). Oocyst development were followed by days 8, 9, 12 and also 15 post-feeding (Fig. 6). This was followed by oocyst detection in the mosquito midgut until 10 to 12 days post-feeding; the lowest amount of oocysts in An. albimanus midgut was observed on day 8 for 3D7 (16.7%) and FCB2 (33.3%), having no statistically significant difference between both strains (p = 0.833), compared to day 12 (53.3% for 3D7 and 60% for FCB2, p = 0.378) (Fig. 7). A similar pattern was seen for An. stephensi infection for 3D7 (33.3%) and FCB2 (50%) on day 8 (p = 0.800) and 3D7 (66.7%) and FCB2 (80%) on day 12 (p = 0.264) (Fig. 7). 3D7 and FCB2 strain oocysts’ morphological characteristics were compared. It was found that most FCB2 oocysts were similar to those from the 3D7 strain regarding their roundness and size, although many oocysts’ growth became stalled, indicating their atrophy (Fig. 8).

Fig. 5

Plasmodium falciparum FCB2 oocyst production. FCB2 oocyst median production on day 9 and 12 post-infection in female mosquitoes infected with FCB2 gametocytes obtained from parasite culture at 0.3% parasitaemia were analysed by Giemsa staining

Fig. 6

Plasmodium falciparum FCB2 oocyst morphological characteristics. Female mosquito midguts infected with FCB2 gametocytes obtained from parasite culture at 0.3% parasitaemia were analysed by 0.5% mercurochrome staining. A FCB2 oocysts day 8 post-infection; B FCB2 oocysts day 9 post-infection; C FCB2 oocysts day 12 post-infection; D FCB2 oocyst day 15 post-infection. All oocysts are indicated by black arrows, visualized at 10X and 40X on a Primo Star Carl Zeiss microscope

Fig. 7

Plasmodium falciparum 3D7 and FCB2 strain oocyst production regarding mosquito species (Anopheles albimanus and Anopheles stephensi). Female mosquito midguts, infected with 3D7 and FCB2 strain gametocytes obtained from parasite culture at 0.3% parasitaemia were analysed by 0.5% mercurochrome staining. a 3D7 and FCB2 oocyst production on day 8 post-infection; b 3D7 and FCB2 oocyst production on day 12 post-infection

Fig. 8

Comparing Plasmodium falciparum 3D7 and FCB2 strains’ oocyst morphological characteristics. Female mosquito midguts infected with FCB2 gametocytes obtained from parasite culture at 0.3% parasitaemia were analysed by 0.5% mercurochrome staining. A, B 3D7 oocysts on day 12 post-infection; C, D FCB2 oocysts on day 12 post-infection. Black arrows indicate viable oocysts; blue arrows show atrophic oocysts. All oocysts visualized at 40X on a Primo Star Carl Zeiss microscope

Even when the percentage of infected mosquito midguts was high on the 1st days studied, only 1.75% of mosquito females had normal oocyst development by day 12 (Figs. 6 and 8). Many factors affect parasite development inside a mosquito midgut, such as the mosquito’s immune response against the parasite (limiting Plasmodium growth and survival in mosquito midgut and haemolymph) [2, 48, 49]) and parasite mechanisms for evading mosquito immune systems (Pfs47-mediated [50, 51] and Pfs47 haplotype variation associated with its geographical origin [11]). Moreover, long-time FCB2 strain in vitro culture could contribute to such low oocyst maturation; it was thus hypothesized that a controlled in vitro environment may induce genomic and/or transcriptomic changes affecting gametocyte production and oocyst maturation. In-depth studies about genomic changes and transcriptional variation in oocyst growth-related genes must be made regarding the parasite’s sexual development in in vitro strains.


Malaria still remains a critical infectious disease because of the stalemate in controlling its progress since 2015 [1]. This problem has mostly been associated with the appearance of parasite resistance to anti-malarial treatment and the mosquito’s resistance to currently available insecticides [52, 53]. Asymptomatic patients (associated with silent host-vector transmission) are related to the disease’s epidemiological persistence thereby highlighting an increasing need for tools enabling the study of parasite transmissible forms [54,55,56,57].

As the parasite’s sexual forms are directly related to host-vector transmission, the in vitro study of antigens blocking this parasite stage is important for attacking this infection. Most studies usually involve using P. falciparum strains which have an already described differentiation capability [43, 58, 59]. Many studies use the NF54 parasite strain because of the ease of gametocyte production; some approaches in Latin-America have used the 7G8 strain [18, 19, 43]. Increasing the amount of characterized P. falciparum strains from other geographical regions having sexual differentiation ability might upgrade variability analysis and provide a better response to the need for anti-malarial drugs and vaccines.

The P. falciparum FCB2 strain was adapted from a severe malaria patient’s isolate and has been kept in in vitro culture for more than 30 years [24]. Most in vitro cultured parasite strains lose their sexual differentiation ability because of mutations in genes associated with the proteins needed for it, such as Pfap2-g [37]. This study has analysed the P. falciparum Colombian FCB2 strain’s sexual differentiation capability by initially verifying Pfap2g, Pfs16, Pfg27/25 and Pfs25 gene expression used for detecting infected patients who could have gametocytes and female parasite sexual forms (Fig. 1) [39,40,41,42, 60]. It is worth noting that the FCB2 strain has preserved its gametocyte production (although to a low degree: 0.2% gametocytes after 12 days culture) after more than 30 years of in vitro culture; it has conserved its characteristic phenotype during each gametocyte stage as seen in other sexually differentiated parasite strains (Fig. 2). These gametocytes were able to form zygotes and ookinetes and exflagellate after in vitro culture with low-temperature stimuli (Figs. 2, 3, 4).

The results highlighted the FCB2 strain’s differentiation ability and indicated its ability to infect mosquitoes. FCB2 strain gametocytes infected Colombian An. albimanus and An. stephensi using a controlled artificial mosquito feeding system; they differentiated into oocyst forms inside mosquito midgut, thereby confirming the conservation of the mosquitoes’ infection ability (Figs. 6 and 8). It is known that culture conditions influence gametocyte formation, i.e. erythrocyte percentage, hypoxanthine and glucose concentration [22, 61, 62]. Serum also influences gametocyte production; gametocyte production and their infectivity become decreased when using serum replacement substances [63]. Probably, such conserved FCB2 gametocyte production could have been associated with culture maintenance conditions, mostly related to parasite culture media always being supplemented with human plasma and this might have helped conserve this feature. Considering the implications of in vitro culture conditions regarding gametocytogenesis, it could be supposed that such conditions may also affect oocyst growth-associated genes, thereby causing impaired development of most of FCB2 oocysts. Genetic comparative analysis comparing high (e.g. NF54) and low (e.g. FCB2) oocyst-producing strains may help to resolve this question and also support the study of possible targets for anti-malarial drugs and vaccine development.

The FCB2 strain’s host geographical origin could also have influenced the amount of infected An. albimanus females and could have been related to the high percentage of oocysts recorded in this study. Mosquito infection potential studies regarding some parasite strains from different regions worldwide have shown that malarial transmission success directly depends on the geographical origin of mosquitoes and parasites [64,65,66]. However, further studies are needed (like the standard membrane-feeding assay using different strains) to confirm this hypothesis and confirming the compatibility between this strain and the geographic origin of An. albimanus.

A mosquito’s parasite infectivity is related to the parasite’s genetic factors enabling mosquitoes to avoid host innate immune response resulting from coevolution of both organisms [15]. Nevertheless, variation in mosquito infectivity has been reported when using P. falciparum isolates from the same geographical area, e.g. African strain NF54 infected 90% of Anopheles gambiae, Kenyan strain K39 infected 86% of An. gambiae, whilst M24 infected only 6% of the same mosquito species [15, 66]. Such huge difference regarding mosquito infection might be explained by variations in parasite strain infection susceptibility associated with mosquito immune response; specifically, increased An. gambiae thioester-containing protein 1 (TEP1) has been shown to be involved in oocyst killing, whilst parasite polymorphism in the Pfs47 gene has enabled evading mosquito immune response [67].

Reports have shown that female An. albimanus infection with the 7G8 Brazilian strain was 68% and average oocyst production was 2 oocysts; such production was small compared to the FCB2 strain studied here (56 oocysts by day 12) and highlighted differences regarding compatibility between South American parasite strains and mosquitoes from the same region [11, 68]. Mosquito innate immune defence mechanisms may influence midgut epithelial ookinete invasion [69, 70]; mosquito immune responses could thus be related to the aforementioned study’s findings. Gametocytaemia, mosquito midgut xanthurenic acid concentration, haemozoin concentration, temperature and other intrinsic mosquito characteristics also influenced FCB2 sporogony formation inside An. albimanus midgut [36, 71]; this might explain the large amount of these forms found on initial days post-feeding compared to the small amount of such forms which finally developed. Moreover, the Anopheline late immune response against oocysts has been described in other mosquito species; haemocytes have been responsible for reduced parasite survival, using unknown mechanisms [72]. Studying haemocyte cell defence response in An. albimanus could be interesting for recognizing its cellular immunity.


This study has thus proposed that the P. falciparum FCB2 strain could be a useful tool for gametocyte production and mosquito infection studies, thereby enabling antigen analysis and comparing anti-malarial drug and vaccine effectiveness. Plasmodium falciparum sexual differentiation and mosquito infection studies can facilitate the identification of parasite survival mechanisms inside Anopheles, parasite strain infection ability and further New World Anopheline malaria-transmission characterization studies.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.



World Health Organization

Ap2-g :

Apetala 2-gametes


falciparum Colombia Bogotá 2


  1. 1.

    WHO. World malaria report 2018. Geneva: World Health Organization; 2018. Accessed 25 Nov 2019.

  2. 2.

    Crompton PD, Moebius J, Portugal S, Waisberg M, Hart G, Garver LS, et al. Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease. Annu Rev Immunol. 2014;32:157–87.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  3. 3.

    Cowman AF, Healer J, Marapana D, Marsh K. Malaria: biology and disease. Cell. 2016;167:610–24.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  4. 4.

    Molina-Cruz A, DeJong RJ, Ortega C, Haile A, Abban E, Rodrigues J, et al. Some strains of Plasmodium falciparum, a human malaria parasite, evade the complement-like system of Anopheles gambiae mosquitoes. Proc Natl Acad Sci USA. 2012;109:E1957–62.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  5. 5.

    Baia-da-Silva DC, Alvarez LCS, Lizcano OV, Costa FTM, Lopes SCP, Orfanó AS, et al. The role of the peritrophic matrix and red blood cell concentration in Plasmodium vivax infection of Anopheles aquasalis. Parasit Vectors. 2018;11:148.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  6. 6.

    Sauerwein RW, Bousema T. Transmission blocking malaria vaccines: assays and candidates in clinical development. Vaccine. 2015;33:7476–82.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  7. 7.

    The malERA Consultative Group on Vaccines. A research agenda for malaria eradication: vaccines. PLoS Med. 2011;8:e1000398.

    PubMed Central  Article  Google Scholar 

  8. 8.

    Amoah LE, Acquah FK, Ayanful-Torgby R, Oppong A, Abankwa J, Obboh EK, et al. Dynamics of anti-MSP3 and Pfs230 antibody responses and multiplicity of infection in asymptomatic children from southern Ghana. Parasit Vectors. 2018;11:13.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  9. 9.

    Blandin S, Shiao S-H, Moita LF, Janse CJ, Waters AP, Kafatos FC, et al. Complement-like protein TEP1 is a determinant of vectorial capacity in the malaria vector Anopheles gambiae. Cell. 2004;116:661–70.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  10. 10.

    Bousema T, Roeffen W, Meijerink H, Mwerinde H, Mwakalinga S, van Gemert G-J, et al. The Dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania. PLoS ONE. 2010;5:e14114.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  11. 11.

    Molina-Cruz A, Canepa GE, Kamath N, Pavlovic NV, Mu J, Ramphul UN, et al. Plasmodium evasion of mosquito immunity and global malaria transmission: the lock-and-key theory. Proc Natl Acad Sci USA. 2015;112:15178–83.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  12. 12.

    Wu Y, Sinden RE, Churcher TS, Tsuboi T, Yusibov V. Development of malaria transmission-blocking vaccines: from concept to product. Adv Parasitol. 2015;89:109–52.

    PubMed  Article  PubMed Central  Google Scholar 

  13. 13.

    Miura K, Takashima E, Deng B, Tullo G, Diouf A, Moretz SE, et al. Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay. Infect Immun. 2013;81:4377–82.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  14. 14.

    Smith RC, Barillas-Mury C, Jacobs-Lorena M. Hemocyte differentiation mediates the mosquito late-phase immune response against Plasmodium in Anopheles gambiae. Proc Natl Acad Sci USA. 2015;112:E3412–20.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  15. 15.

    Molina-Cruz A, Canepa GE, Barillas-Mury C. Plasmodium P47: a key gene for malaria transmission by mosquito vectors. Curr Opin Microbiol. 2017;40:168–74.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  16. 16.

    Garver LS, Bahia AC, Das S, Souza-Neto JA, Shiao J, Dong Y, et al. Anopheles Imd pathway factors and effectors in infection intensity-dependent anti-Plasmodium action. PLoS Pathog. 2012;8:e1002737.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  17. 17.

    Canepa GE, Molina-Cruz A, Barillas-Mury C. Molecular analysis of Pfs47-mediated Plasmodium evasion of mosquito immunity. PLoS ONE. 2016;11:e0168279.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  18. 18.

    Pimenta PF, Orfano AS, Bahia AC, Duarte AP, Ríos-Velásquez CM, Melo FF, et al. An overview of malaria transmission from the perspective of Amazon Anopheles vectors. Mem Inst Oswaldo Cruz. 2015;110:23–47.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  19. 19.

    Zapata JC, Perlaza BL, Hurtado S, Quintero GE, Jurado D, González I, et al. Reproducible infection of intact Aotus lemurinus griseimembra monkeys by Plasmodium falciparum sporozoite inoculation. J Parasitol. 2002;88:723–9.

    PubMed  Article  PubMed Central  Google Scholar 

  20. 20.

    Olano VA, Carrillo MP, de la Vega P, Espinal CA. Vector competence of Cartagena strain of Anopheles albimanus for Plasmodium falciparum and P. vivax. Trans R Soc Trop Med Hyg. 1985;79:685–6.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  21. 21.

    Hurtado S, Salas ML, Romero JF, Zapata JC, Ortiz H, Arevalo-Herrera M, et al. Regular production of infective sporozoites of Plasmodium falciparum and P. vivax in laboratory-bred Anopheles albimanus. Ann Trop Med Parasitol. 1997;91:49–60.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  22. 22.

    Delves MJ, Straschil U, Ruecker A, Miguel-Blanco C, Marques S, Dufour AC, et al. Routine in vitro culture of P. falciparum gametocytes to evaluate novel transmission-blocking interventions. Nat Protoc. 2016;11:1668–80.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  23. 23.

    Claessens A, Affara M, Assefa SA, Kwiatkowski DP, Conway DJ. Culture adaptation of malaria parasites selects for convergent loss-of-function mutants. Sci Rep. 2017;7:41303.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  24. 24.

    Espinal TC, Moreno E, Guerra P, De La Vega P. Aislamiento y caracterización de cepas colombiana de Plasmodium falciparum. Biomédica. 1982;2:118.

    Article  Google Scholar 

  25. 25.

    Curtidor H, Vanegas M, Alba MP, Patarroyo ME. Functional, immunological and three-dimensional analysis of chemically synthesised sporozoite peptides as components of a fully-effective antimalarial vaccine. Curr Med Chem. 2011;18:4470–502.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  26. 26.

    Rodriguez LE, Curtidor H, Urquiza M, Cifuentes G, Reyes C, Patarroyo ME. Intimate molecular interactions of P. falciparum merozoite proteins involved in invasion of red blood cells and their implications for vaccine design. Chem Rev. 2008;108:3656–705.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  27. 27.

    Vásquez A, Segura C, Blair S. Induction of pro-inflammatory response of the placental trophoblast by Plasmodium falciparum infected erythrocytes and TNF. Malar J. 2013;12:421.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  28. 28.

    Malkin EM, Durbin AP, Diemert DJ, Sattabongkot J, Wu Y, Miura K, et al. Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria. Vaccine. 2005;23:3131–8.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  29. 29.

    Wu Y, Ellis RD, Shaffer D, Fontes E, Malkin EM, Mahanty S, et al. Phase 1 Trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with Montanide ISA 51. PLoS ONE. 2008;3:e2636.

    PubMed  PubMed Central  Article  Google Scholar 

  30. 30.

    Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976;193:673–5.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  31. 31.

    Suaréz-Cortés P, Silvestrini F, Alano P. A fast, non-invasive, quantitative staining protocol provides insights in Plasmodium falciparum gamete egress and in the role of osmiophilic bodies. Malar J. 2014;13:389.

    PubMed  PubMed Central  Article  Google Scholar 

  32. 32.

    Osoga J, Waitumbi J, Guyah B, Sande J, Arima C, Ayaya M, et al. Comparative evaluation of fluorescent in situ hybridization and Giemsa microscopy with quantitative real-time PCR technique in detecting malaria parasites in a holoendemic region of Kenya. Malar J. 2017;16:297.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  33. 33.

    Arévalo-Pinzón G, Curtidor H, Muñoz M, Suarez D, Patarroyo MA, Patarroyo ME. Rh1 high activity binding peptides inhibit high percentages of Plasmodium falciparum FVO strain invasion. Vaccine. 2013;31:1830–7.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  34. 34.

    Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, et al. Clustal W and Clustal X version 2.0. Bioinformatics. 2007;23:2947–8.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  35. 35.

    Kennedy M, Fishbaugher ME, Vaughan AM, Patrapuvich R, Boonhok R, Yimamnuaychok N, et al. A rapid and scalable density gradient purification method for Plasmodium sporozoites. Malar J. 2012;11:421.

    PubMed  PubMed Central  Article  Google Scholar 

  36. 36.

    Li T, Eappen AG, Richman AM, Billingsley PF, Abebe Y, Li M, et al. Robust, reproducible, industrialized, standard membrane feeding assay for assessing the transmission blocking activity of vaccines and drugs against Plasmodium falciparum. Malar J. 2015;14:150.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  37. 37.

    Kafsack BFC, Rovira-Graells N, Clark TG, Bancells C, Crowley VM, Campino SG, et al. A transcriptional switch underlies commitment to sexual development in malaria parasites. Nature. 2014;507:248–52.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  38. 38.

    Modrzynska K, Pfander C, Chappell L, Yu L, Suarez C, Dundas K, et al. A Knockout screen of ApiAP2 genes reveals networks of interacting transcriptional regulators controlling the Plasmodium life cycle. Cell Host Microbe. 2017;21:11–22.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  39. 39.

    Alano P, Premawansa S, Bruce MC, Carter R. A stage specific gene expressed at the onset of gametocytogenesis in Plasmodium falciparum. Mol Biochem Parasitol. 1991;46:81–8.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  40. 40.

    Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol. 2014;12:833–40.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  41. 41.

    Kongkasuriyachai D, Fujioka H, Kumar N. Functional analysis of Plasmodium falciparum parasitophorous vacuole membrane protein (Pfs16) during gametocytogenesis and gametogenesis by targeted gene disruption. Mol Biochem Parasitol. 2004;133:275–85.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  42. 42.

    Wampfler R, Mwingira F, Javati S, Robinson L, Betuela I, Siba P, et al. Strategies for detection of Plasmodium species gametocytes. PLoS ONE. 2013;8:e76316.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  43. 43.

    Talman AM, Domarle O, McKenzie FE, Ariey F, Robert V. Gametocytogenesis: the puberty of Plasmodium falciparum. Malar J. 2004;3:24.

    PubMed  PubMed Central  Article  Google Scholar 

  44. 44.

    Baker DA. Malaria gametocytogenesis. Mol Biochem Parasitol. 2010;172:57–65.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  45. 45.

    Bousema T, Drakeley C. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev. 2011;24:377–410.

    PubMed  PubMed Central  Article  Google Scholar 

  46. 46.

    Gebru T, Lalremruata A, Kremsner PG, Mordmüller B, Held J. Life-span of in vitro differentiated Plasmodium falciparum gametocytes. Malar J. 2017;16:330.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  47. 47.

    Ghosh AK, Dinglasan RR, Ikadai H, Jacobs-Lorena M. An improved method for the in vitro differentiation of Plasmodium falciparum gametocytes into ookinetes. Malar J. 2010;9:194.

    PubMed  PubMed Central  Article  Google Scholar 

  48. 48.

    Bartholomay LC, Michel K. Mosquito immunobiology: the intersection of vector health and vector competence. Annu Rev Entomol. 2018;63:145–67.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  49. 49.

    Smith RC, Vega-Rodríguez J, Jacobs-Lorena M. The Plasmodium bottleneck: malaria parasite losses in the mosquito vector. Mem Inst Oswaldo Cruz. 2014;109:644–61.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  50. 50.

    Molina-Cruz A, Garver LS, Alabaster A, Bangiolo L, Haile A, Winikor J, et al. The human malaria parasite Pfs47 gene mediates evasion of the mosquito immune system. Science. 2013;340:984–7.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  51. 51.

    Ramphul UN, Garver LS, Molina-Cruz A, Canepa GE, Barillas-Mury C. Plasmodium falciparum evades mosquito immunity by disrupting JNK-mediated apoptosis of invaded midgut cells. Proc Natl Acad Sci USA. 2015;112:1273–80.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  52. 52.

    Amato R, Pearson RD, Almagro-Garcia J, Amaratunga C, Lim P, Suon S, et al. Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study. Lancet Infect Dis. 2018;18:337–45.

    PubMed  PubMed Central  Article  Google Scholar 

  53. 53.

    Ranson H, Lissenden N. Insecticide resistance in African Anopheles mosquitoes: a worsening situation that needs urgent action to maintain malaria control. Trends Parasitol. 2016;32:187–96.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  54. 54.

    Hassanpour G, Mohebali M, Zeraati H, Raeisi A, Keshavarz H. Asymptomatic malaria and its challenges in the malaria elimination program in Iran: a systematic review. J Arthropod-Borne Dis. 2017;11:172–81.

    PubMed  PubMed Central  Google Scholar 

  55. 55.

    Kapesa A, Kweka EJ, Atieli H, Afrane YA, Kamugisha E, Lee M-C, et al. The current malaria morbidity and mortality in different transmission settings in Western Kenya. PLoS ONE. 2018;13:e0202031.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  56. 56.

    Lin JT, Saunders DL, Meshnick SR. The role of submicroscopic parasitemia in malaria transmission: what is the evidence? Trends Parasitol. 2014;30:183–90.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  57. 57.

    Vásquez-Jiménez JM, Arévalo-Herrera M, Henao-Giraldo J, Molina-Gómez K, Arce-Plata M, Vallejo AF, et al. Consistent prevalence of asymptomatic infections in malaria endemic populations in Colombia over time. Malar J. 2016;15:70.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  58. 58.

    Ponnudurai T, Lensen AHW, Van Gemert GJA, Bensink MPE, Bolmer M, Meuwissen JHETh. Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes. Parasitology. 1989;98:165.

    PubMed  Article  PubMed Central  Google Scholar 

  59. 59.

    Itsara LS, Zhou Y, Do J, Dungel S, Fishbaugher ME, Betz WW, et al. PfCap380 as a marker for Plasmodium falciparum oocyst development in vivo and in vitro. Malar J. 2018;17:135.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  60. 60.

    Kast K, Berens-Riha N, Zeynudin A, Abduselam N, Eshetu T, Löscher T, et al. Evaluation of Plasmodium falciparum gametocyte detection in different patient material. Malar J. 2013;12:438.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  61. 61.

    Ifediba T, Vanderberg JP. Complete in vitro maturation of Plasmodium falciparum gametocytes. Nature. 1981;294:364–6.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  62. 62.

    Schuster FL. Cultivation of Plasmodium spp. Clin Microbiol Rev. 2002;15:355–64.

    PubMed  PubMed Central  Article  Google Scholar 

  63. 63.

    Lingnau A, Margos G, Maier WA, Seitz HM. Serum-free cultivation of Plasmodium falciparum gametocytes in vitro. Parasitol Res. 1993;79:378–84.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  64. 64.

    Baton LA, Ranford-Cartwright LC. Ookinete destruction within the mosquito midgut lumen explains Anopheles albimanus refractoriness to Plasmodium falciparum (3D7A) oocyst infection. Int J Parasitol. 2012;42:249–58.

    PubMed  PubMed Central  Article  Google Scholar 

  65. 65.

    Grieco JP, Achee NL, Roberts DR, Andre RG. Comparative susceptibility of three species of Anopheles from Belize, Central America, to Plasmodium falciparum (NF-54). J Am Mosq Control Assoc. 2005;21:279.

    PubMed  Article  PubMed Central  Google Scholar 

  66. 66.

    Hume JC, Tunnicliff M, Ranford-Cartwright LC, Day KP. Susceptibility of Anopheles gambiae and Anopheles stephensi to tropical isolates of Plasmodium falciparum. Malar J. 2007;6:139.

    PubMed  PubMed Central  Article  Google Scholar 

  67. 67.

    Eldering M, Morlais I, van Gemert G-J, van de Vegte-Bolmer M, Graumans W, Siebelink-Stoter R, et al. Variation in susceptibility of African Plasmodium falciparum malaria parasites to TEP1 mediated killing in Anopheles gambiae mosquitoes. Sci Rep. 2016;6:20440.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  68. 68.

    Orfano AS, Duarte APM, Molina-Cruz A, Pimenta PF, Barillas-Mury C. Plasmodium yoelii nigeriensis (N67) is a robust animal model to study malaria transmission by South American Anopheline mosquitoes. PLoS ONE. 2016;11:e0167178.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  69. 69.

    Jaramillo-Gutierrez G, Rodrigues J, Ndikuyeze G, Povelones M, Molina-Cruz A, Barillas-Mury C. Mosquito immune responses and compatibility between Plasmodium parasites and anopheline mosquitoes. BMC Microbiol. 2009;9:154.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  70. 70.

    Shaw WR, Catteruccia F. Vector biology meets disease control: using basic research to fight vector-borne diseases. Nat Microbiol. 2019;4:20–34.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  71. 71.

    Hauck ES, Antonova-Koch Y, Drexler A, Pietri J, Pakpour N, Liu D, et al. Overexpression of phosphatase and tensin homolog improves fitness and decreases Plasmodium falciparum development in Anopheles stephensi. Microbes Infect. 2013;15:775–87.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  72. 72.

    Smith RC, Barillas-Mury C. Plasmodium oocysts: overlooked targets of mosquito immunity. Trends Parasitol. 2016;32:979–90.

    PubMed  Article  PubMed Central  Google Scholar 

Download references


The authors would like to thank Doctors Michael Delves and Diana Díaz for their help regarding parasite maintenance and gametocyte production and Doctor Ligia Inés Moncada for her helpful hints for mosquito breeding; Bei Resources for donating the P. falciparum 3D7 strain; the Instituto Nacional de Salud (INS) de Colombia for An. albimanus egg donation; Doctors Ana Catarina Alves, Henrique Silveira and João Pinto from the Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Portugal, for donating An. stephensi eggs; the Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud (IDCBIS) for donating the human plasma; Doctor Armando Moreno-Vranich for improving the quality of the images, Doctors Iván Darío Vélez and María Alejandra Vélez from PECET, Universidad de Antioquia, for helping us to restart mosquito infection experiments and Jason Garry for revising the manuscript.


This work was financed by the Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS) through PhD scholarships, “Doctorado Nacional, Convocatoria – 647” and “Doctorado Nacional, Convocatoria 617”.

Author information




MAS and CCP conceived the work, drafted the manuscript and designed the figures. CCP, LTO and PAC performed the experiments. MC did the statistical analysis and designed figures. MAP and HC critically revised the manuscript for intellectual content. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Manuel Alfonso Patarroyo.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ararat-Sarria, M., Prado, C.C., Camargo, M. et al. Sexual forms obtained in a continuous in vitro cultured Colombian strain of Plasmodium falciparum (FCB2). Malar J 19, 57 (2020).

Download citation


  • Malaria
  • Plasmodium falciparum
  • FCB2
  • Sexual differentiation
  • Mosquito infectivity
  • Gametocyte
  • Oocyst